Global Blood Therapeutics Inc (GBT) has risen Monday morning, with the stock adding 2.44% in pre-market trading to 65.4. GBT's short-term technical score of 100 indicates that the stock has traded more bullishly over the last month than 100% of stocks on the market. In the Biotechnology industry, which ranks 107 out of 146 industries, the stock ranks higher than 100% of stocks. Global Blood Therapeutics Inc has risen 83.19% over the past month, closing at $33.71 on July 11. During this period of time, the stock fell as low as $32.40 and as high as $73.02. GBT has an average analyst recommendation of Strong Buy. The company has an average price target of $59.80.
Global Blood Therapeutics Inc has a Long-Term Technical rank of 100. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 0% of the market scoring higher. In the Biotechnology industry which is number 71 by this metric, GBT ranks better than 71% of stocks.
Premarket Mover: Global Blood Therapeutics Inc (GBT) Up 2.44%
GBT has an Overall Score of 67. Find out what this means to you and get the rest of the rankings on GBT!